Syringe Services Programs’ Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them

[1]  A. Deshpande,et al.  Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic , 2020, Harm Reduction Journal.

[2]  S. Bellamy,et al.  Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE demonstration study. , 2020, Journal of acquired immune deficiency syndromes.

[3]  R. Bluthenthal,et al.  HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016–2018 , 2020, Substance use & misuse.

[4]  S. Allen,et al.  Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia , 2020, AIDS care.

[5]  Christopher M. Jones,et al.  Infectious Diseases and Injection Drug Use: Public Health Burden and Response. , 2020, The Journal of infectious diseases.

[6]  K. Brady,et al.  Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia. , 2020, The Journal of infectious diseases.

[7]  S. Lyss,et al.  Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs-United States, 2016-2019: Perspectives on Recent Experience and Lessons Learned. , 2020, The Journal of infectious diseases.

[8]  M. Johnston,et al.  Roles for Pharmacists in the “Ending the HIV Epidemic: A Plan for America” Initiative , 2020, Public health reports.

[9]  M. Copenhaver,et al.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review , 2020, AIDS and Behavior.

[10]  C. Cunningham,et al.  A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection , 2020, AIDS and Behavior.

[11]  D. Feaster,et al.  Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis , 2020, The International journal on drug policy.

[12]  S. Burris,et al.  State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019 , 2020, Public health reports.

[13]  S. Friedman,et al.  Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks , 2020, Journal of the International AIDS Society.

[14]  S. Nair,et al.  HIV Testing Trends at Visits to Physician Offices, Community Health Centers, and Emergency Departments — United States, 2009–2017 , 2020, MMWR. Morbidity and mortality weekly report.

[15]  J. S. St. Onge,et al.  The University of Miami Infectious Disease Elimination Act Syringe Services Program: A Blueprint for Student Advocacy, Education, and Innovation , 2020, Academic medicine : journal of the Association of American Medical Colleges.

[16]  L. Metsch,et al.  Syringe services program (SSP) operational changes during the COVID-19 global outbreak , 2020, International Journal of Drug Policy.

[17]  Catherine Duplessy,et al.  HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service , 2020, Harm Reduction Journal.

[18]  D. D. Des Jarlais,et al.  The Impact of COVID-19 on Syringe Services Programs in the United States , 2020, AIDS and Behavior.

[19]  Ellsworth M. Campbell,et al.  Notes from the Field: Outbreak of Human Immunodeficiency Virus Infection Among Persons Who Inject Drugs — Cabell County, West Virginia, 2018–2019 , 2020, MMWR. Morbidity and mortality weekly report.

[20]  Allan E. Rodriguez,et al.  Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida , 2020, PloS one.

[21]  Jordan G Sheppard,et al.  Syringe services programs and real-world research: An overview for pharmacists. , 2020, Journal of the American Pharmacists Association : JAPhA.

[22]  A. Noroozi,et al.  Factors associated with HIV testing among people who inject drugs: a meta-analysis , 2020, Journal of addictive diseases.

[23]  D. D. Des Jarlais,et al.  HIV outbreaks among people who inject drugs in Europe, North America, and Israel. , 2020, The lancet. HIV.

[24]  D. Feaster,et al.  Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis. , 2020, The International journal on drug policy.

[25]  K. Smith,et al.  Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study , 2019, AIDS and Behavior.

[26]  Ellsworth M. Campbell,et al.  Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018. , 2019, American journal of public health.

[27]  David R. Holtgrave,et al.  Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia , 2019, Journal of acquired immune deficiency syndromes.

[28]  C. Davis,et al.  Paraphernalia Laws, Criminalizing Possession and Distribution of Items Used to Consume Illicit Drugs, and Injection-Related Harm. , 2019, American journal of public health.

[29]  Emma C Spencer,et al.  Rapid Identification and Investigation of an HIV Risk Network Among People Who Inject Drugs –Miami, FL, 2018 , 2019, AIDS and Behavior.

[30]  Emma C Spencer,et al.  Syringe disposal among people who inject drugs before and after the implementation of a syringe services program. , 2019, Drug and alcohol dependence.

[31]  D. D. Des Jarlais,et al.  Implementing an Updated “Break the Cycle” Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US “opioid epidemic” Setting , 2019, AIDS and Behavior.

[32]  C. Golin,et al.  Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs. , 2019, AIDS education and prevention : official publication of the International Society for AIDS Education.

[33]  S. Galea,et al.  Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  S. Allen,et al.  Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs , 2019, Harm Reduction Journal.

[35]  Christopher M. Jones.  Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S. , 2019, The International journal on drug policy.

[36]  J. Rich,et al.  Lessons from Scott County - Progress or Paralysis on Harm Reduction? , 2019, The New England journal of medicine.

[37]  R. Lechtenberg,et al.  Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs — Seattle, Washington, 2018 , 2019, MMWR. Morbidity and mortality weekly report.

[38]  Allison J. Ober,et al.  Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia , 2019, Harm Reduction Journal.

[39]  R. Redfield,et al.  Ending the HIV Epidemic: A Plan for the United States. , 2019, JAMA.

[40]  S. Allen,et al.  PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. , 2019, Drug and alcohol dependence.

[41]  B. Marshall,et al.  Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs. , 2019, The lancet. HIV.

[42]  M. Mimiaga,et al.  Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions , 2019, BMC Public Health.

[43]  M. Mimiaga,et al.  Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs , 2018, Harm Reduction Journal.

[44]  J. Ward,et al.  A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015 , 2018, EBioMedicine.

[45]  S. Davis,et al.  Qualitative case study of needle exchange programs in the Central Appalachian region of the United States , 2018, PloS one.

[46]  A. Martinez-Donate,et al.  "I Don't Need PrEP Right Now": A Qualitative Exploration of the Barriers to PrEP Care Engagement Through the Application of the Health Belief Model. , 2018, AIDS education and prevention : official publication of the International Society for AIDS Education.

[47]  Forrest W. Crawford,et al.  Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study. , 2018, The lancet. HIV.

[48]  D. D. Des Jarlais,et al.  Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. , 2018, Journal of acquired immune deficiency syndromes.

[49]  J. Niederdeppe,et al.  Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. , 2018, Preventive medicine.

[50]  F. Altice,et al.  Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? , 2018, Current HIV/AIDS Reports.

[51]  S. Proescholdbell,et al.  Access to Syringe Services Programs — Kentucky, North Carolina, and West Virginia, 2013–2017 , 2018, MMWR. Morbidity and mortality weekly report.

[52]  M. Dubey,et al.  Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition , 2018, Current HIV/AIDS Reports.

[53]  B. Meyerson,et al.  Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions , 2018, The International journal on drug policy.

[54]  C. Strike,et al.  Scoping out the literature on mobile needle and syringe programs—review of service delivery and client characteristics, operation, utilization, referrals, and impact , 2018, Harm Reduction Journal.

[55]  P. Peters,et al.  Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana. , 2018, The International journal on drug policy.

[56]  J. Brooks,et al.  Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak , 2017, Journal of acquired immune deficiency syndromes.

[57]  H. Hagan,et al.  Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis , 2017, Addiction.

[58]  A. Martinez-Donate,et al.  An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users , 2017, Sexually transmitted diseases.

[59]  K. Carroll,et al.  The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. , 2017, The American journal of psychiatry.

[60]  J. Whitcomb,et al.  Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  D. D. Des Jarlais.  Harm reduction in the USA: the research perspective and an archive to David Purchase , 2017, Harm Reduction Journal.

[62]  Huiru Dong,et al.  Syringe Sharing Among a Prospective Cohort of Street-Involved Youth: Implications for Needle Distribution Programs , 2017, AIDS and Behavior.

[63]  T. Khan,et al.  Effectiveness of pharmacy‐based needle/syringe exchange programme for people who inject drugs: a systematic review and meta‐analysis , 2017, Addiction.

[64]  V. Patel,et al.  Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs , 2017, AIDS and Behavior.

[65]  Michael W. Spiller,et al.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. , 2016, The New England journal of medicine.

[66]  M. Jauffret-Roustide,et al.  HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. , 2016, AIDS.

[67]  A. Greenberg,et al.  Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. , 2016, Drug and alcohol dependence.

[68]  K. Clarke,et al.  The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California , 2016, Social work in public health.

[69]  J. Zibbell,et al.  Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014 , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[70]  Richard Weinmeyer.  Needle Exchange Programs' Status in US Politics. , 2016, AMA journal of ethics.

[71]  L. Adams,et al.  HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report , 2016, AIDS care.

[72]  D. Holtzman,et al.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013. , 2015, MMWR. Morbidity and mortality weekly report.

[73]  S. Allen,et al.  Impact Evaluation of a Policy Intervention for HIV Prevention in Washington, DC , 2015, AIDS and Behavior.

[74]  Christopher M. Jones,et al.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users — United States, 2002–2013 , 2015, MMWR. Morbidity and mortality weekly report.

[75]  G. E. Harris,et al.  Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. , 2015, Drug and alcohol dependence.

[76]  D. D. Des Jarlais,et al.  State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness , 2015, Journal of public health policy.

[77]  M. Hellard,et al.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. , 2014, International journal of epidemiology.

[78]  S. Paul,et al.  Integrating Health and Prevention Services in Syringe Access Programs: A Strategy to Address Unmet Needs in a High-Risk Population , 2014, Public health reports.

[79]  A. Pharris,et al.  Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. , 2014, The International journal on drug policy.

[80]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[81]  J. Maxwell.  The prescription drug epidemic in the United States: a perfect storm. , 2011, Drug and alcohol review.

[82]  H. Sumnall,et al.  Optimal provision of needle and syringe programmes for injecting drug users: A systematic review. , 2010, The International journal on drug policy.

[83]  T. Rhodes,et al.  Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed , 2010, The Lancet.

[84]  J. Montaner,et al.  Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. , 2010, American journal of public health.

[85]  D. D. Des Jarlais,et al.  Organizational Issues in the Implementation of a Hospital-Based Syringe Exchange Program , 2010, Substance use & misuse.

[86]  C. Magis-Rodríguez,et al.  Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico. , 2009, The International journal on drug policy.

[87]  J. Havens,et al.  Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. , 2009, Journal of substance abuse treatment.

[88]  M Mofizul Islam,et al.  The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. , 2008, The International journal on drug policy.

[89]  D. D. Des Jarlais,et al.  Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. , 2008, The International journal on drug policy.

[90]  J. Neale,et al.  Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. , 2007, Health & social care in the community.

[91]  D. Moore.  Needle stick injuries in the community. , 2008, Paediatrics & child health.

[92]  R. D. Bruce,et al.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  R. Bluthenthal,et al.  Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. , 2007, Drug and alcohol dependence.

[94]  S. Hall,et al.  Hospital- versus community-based syringe exchange: a randomized controlled trial. , 2007, AIDS education and prevention : official publication of the International Society for AIDS Education.

[95]  Terry L. Schell,et al.  Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. , 2007, Addiction.

[96]  J. Havens,et al.  Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. , 2006, Drug and alcohol dependence.

[97]  S. Asch,et al.  Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. , 2006, Drug and alcohol dependence.

[98]  A. Wodak,et al.  Do Needle Syringe Programs Reduce HIV Infection Among Injecting Drug Users: A Comprehensive Review of the International Evidence , 2006, Substance use & misuse.

[99]  C. Latkin,et al.  Needle Exchange Program Utilization and Entry into Drug User Treatment: Is There a Long-Term Connection in Baltimore, Maryland? , 2006, Substance use & misuse.

[100]  S. Kegeles,et al.  Secondary syringe exchange among injection drug users , 2003, Journal of Urban Health.

[101]  Don C Des Jarlais,et al.  HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. , 2005, American journal of public health.

[102]  R P Mattick,et al.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. , 2008, The Cochrane database of systematic reviews.

[103]  D. Metzger,et al.  Human immunodeficiency virus prevention and the potential of drug abuse treatment. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[104]  A. Fenaughty,et al.  Needle exchange and injection drug use frequency: a randomized clinical trial. , 2003, Journal of acquired immune deficiency syndromes.

[105]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[106]  S. Galea,et al.  Needle Exchange Programs and Experience of Violence in an Inner City Neighborhood , 2001, Journal of acquired immune deficiency syndromes.

[107]  R. Brookmeyer,et al.  Trends in crime and the introduction of a needle exchange program. , 2000, American journal of public health.

[108]  J. Duchin,et al.  Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. , 2000, Journal of substance abuse treatment.

[109]  L. Metsch,et al.  A Comparison of the Need for Health Care and Use of Health Care by Injection-Drug Users, Other Chronic Drug Users, and Nondrug Users , 1998 .

[110]  P. Lurie,et al.  An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA , 1997, The Lancet.

[111]  Samuel R Friedman,et al.  HIV incidence among injecting drug users in New York City syringe-exchange programmes , 1996, The Lancet.

[112]  D. D. Des Jarlais,et al.  Maintaining low HIV seroprevalence in populations of injecting drug users. , 1995, JAMA.

[113]  E. H. Kaplan,et al.  Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. , 1993, The American journal of medicine.